Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Unique MicroRNA Molecular Profiles In Lung Cancer Diagnosis And Prognosis

  • Read more about Unique MicroRNA Molecular Profiles In Lung Cancer Diagnosis And Prognosis
US Application 60/756,400
Filed on 2006-01-05

EXTRACELLULAR MATRIX/METASTASIS MODIFIER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR

  • Read more about EXTRACELLULAR MATRIX/METASTASIS MODIFIER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR
US Application 60/788,463
Filed on 2006-03-31

Diazeniumdiolated Non-Steroidal Anti-Inflammatory Drugs, Compositions Thereof, and Related Methods

  • Read more about Diazeniumdiolated Non-Steroidal Anti-Inflammatory Drugs, Compositions Thereof, and Related Methods
US Application 60/794,421
Filed on 2006-04-24

Materials and Methods Directed to Asparagine Synthetase and Asparaginase Therapies

  • Read more about Materials and Methods Directed to Asparagine Synthetase and Asparaginase Therapies
US Application 60/833,027
Filed on 2006-07-25

INHIBITING TUMOR CELL GROWTH WITH FACTOR OBTAINED FROM GRAPE SKIN EXTRACT

  • Read more about INHIBITING TUMOR CELL GROWTH WITH FACTOR OBTAINED FROM GRAPE SKIN EXTRACT
US Application 60/789,181
Filed on 2006-04-03

SgrT: A Novel Small Molecule Protein Inhibitor Of Bacterial Glucose Metabolism

  • Read more about SgrT: A Novel Small Molecule Protein Inhibitor Of Bacterial Glucose Metabolism
US Application 60/799,830
Filed on 2006-05-11

Diamidine inhibitors of TDP1

  • Read more about Diamidine inhibitors of TDP1
US Application 60/786,604
Filed on 2006-03-27

Pharmacokinetics Of The Histone Deacetylase (HDAC) Inhibitor, In Non-human Primates

  • Read more about Pharmacokinetics Of The Histone Deacetylase (HDAC) Inhibitor, In Non-human Primates
US Application 60/787,726
Filed on 2006-03-30

A Method To Develop B-Cell Epitope Based Effective Vaccine Modalities For Smallpox For Both Immune-Competent And Immune-Compromised Individuals

  • Read more about A Method To Develop B-Cell Epitope Based Effective Vaccine Modalities For Smallpox For Both Immune-Competent And Immune-Compromised Individuals
US Application 60/722,082
Filed on 2005-09-21

The Manganese Superoxide Dismutase Val16Ala Polymorphism Predicts Resistance To Adriamycin (Doxorubicin) In Breast Cancer Therapy

  • Read more about The Manganese Superoxide Dismutase Val16Ala Polymorphism Predicts Resistance To Adriamycin (Doxorubicin) In Breast Cancer Therapy
US Application 60/799,788
Filed on 2006-05-11

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 146
  • Page 147
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health